Ronen Tamir
Public Communications Contact chez PFIZER, INC.
Profil
Ronen Tamir is currently the Vice President-Investor Relations at Pfizer Inc. He previously worked as the Director-Business Intelligence at EMD Serono, Inc., the Chief Commercialization Officer at Rosetta Genomics Ltd., and the Vice President-Investor Relations at Novartis AG.
Tamir holds an MBA from Warwick Business School and an undergraduate degree from Bar-Ilan University.
Postes actifs de Ronen Tamir
| Sociétés | Poste | Début |
|---|---|---|
| PFIZER, INC. | Public Communications Contact | 01/10/2021 |
Anciens postes connus de Ronen Tamir
| Sociétés | Poste | Fin |
|---|---|---|
| NOVARTIS AG | Investor Relations Contact | - |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | - |
| ROSETTA GENOMICS LTD. | Corporate Officer/Principal | - |
Formation de Ronen Tamir
| Bar-Ilan University | Undergraduate Degree |
| Warwick Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ROSETTA GENOMICS LTD. | Health Technology |
| NOVARTIS AG | Health Technology |
| PFIZER, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
